P

Premier Clinical Research Institute, Inc. | Miami, FL

Research site
(Unclaimed)
Location
3100 NW 72nd Avenue Suite 125, Miami, Florida, United States of America

Site insights

Top conditions

Top treatments

Pimavanserin
AVP-786
SEP-363856
NaBen®
Semaglutide
SEP-4199
ACP-204
Semagludtide
PCN-101
Quetiapine

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 18 total trials

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants will either get sem...

Active, not recruiting
Early Alzheimer´s Disease
Drug: Placebo (semaglutide)
Drug: Semaglutide

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants will either get sem...

Active, not recruiting
Early Alzheimer's Disease
Drug: Placebo (semaglutide)
Drug: Semagludtide

This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies...

Enrolling
Alzheimer's Disease Psychosis
Drug: Placebo
Drug: ACP-204

An Extension study to a clinical study that will continue to evaluate the effectiveness and safety of SEP-363856 in people with schizophrenia that sw...

Invitation-only
Schizophrenia
Drug: SEP-363856

Trial sponsors

Acadia Pharmaceuticals logo
Otsuka logo
Sumitomo Pharma logo
Novo Nordisk logo
Biogen logo
P
S
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems